ArticleCNS drugs2026

Correction: Evaluation of Safety, Pharmacokinetic, and Pharmacodynamic Characteristics of a Novel Dual mGluR5/5‑HT2AR Antagonist (VVZ‑2471) in a Randomized, Double‑Blind, First‑in‑Human Study.

Sungyeun Bae et al.PubMed ↗Publisher ↗

No numbers read from the abstract.